Spots Global Cancer Trial Database for hilar cholangiocarcinoma
Every month we try and update this database with for hilar cholangiocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma | NCT03104569 | Cholangitis | Injection of 37... | 18 Years - 90 Years | Hepatopancreatobiliary Surgery Institute of Gansu Province | |
| Fluorescence Image Guided Surgery in Cholangiocarcinoma | NCT03620292 | Hilar Cholangio... | Bevacizumab-IRD... near infrared (... | 18 Years - | University Medical Center Groningen | |
| Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma | NCT02955771 | Hilar Cholangio... | PDT-Deuteporfin... PDT-Deuteporfin... stenting | 18 Years - | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | |
| Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) | NCT03739164 | Liver Cancer Liver Tumor Hepatocellular ... Hilar Cholangio... | 18 Years - 80 Years | Florida Hospital Tampa Bay Division | ||
| Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma | NCT03132649 | Hilar Cholangio... | 18 Years - 70 Years | Zhujiang Hospital | ||
| Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma | NCT00721175 | Hilar Cholangio... | biliary stent (... PS | 18 Years - | Khon Kaen University | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma | NCT04611100 | Hilar Cholangio... Biliary Obstruc... | ELRA endolumina... | 18 Years - 80 Years | Rajavithi Hospital | |
| Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent | NCT00746538 | Unresectable Hi... | biliary stent | 18 Years - | Khon Kaen University | |
| Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma | NCT02108145 | Hilar Cholangio... | bilateral metal... unilateral meta... | 18 Years - 90 Years | Air Force Military Medical University, China | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | NCT02178280 | Hilar Cholangio... | liver transplan... | 18 Years - 65 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer | NCT04561453 | Biliary Tract C... Cholangiocarcin... Gallbladder Can... Intrahepatic Ch... Perihilar Chola... Extrahepatic Ch... Hilar Cholangio... Distal Bile Duc... | Multi-Platform ... | 18 Years - | University of Washington | |
| Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | NCT01549795 | Hilar Cholangio... Primary Scleros... | Liver transplan... 45 Gy external ... Endoluminal bil... Capecitabine Pre liver trans... | 18 Years - 65 Years | Azienda Ospedaliera di Padova | |
| Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | NCT02178280 | Hilar Cholangio... | liver transplan... | 18 Years - 65 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers | NCT04211168 | Advanced Biliar... | Toripalimab plu... | 18 Years - | Peking Union Medical College Hospital | |
| Optimization of Health Expenditure in Liver Surgery | NCT01715402 | Hepatocellular ... Hilar Cholangio... Intra Hepatic C... Liver Metastasi... | liver surgery | 18 Years - | Centre Hospitalier Universitaire, Amiens | |
| Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent | NCT00746538 | Unresectable Hi... | biliary stent | 18 Years - | Khon Kaen University | |
| Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | NCT01549795 | Hilar Cholangio... Primary Scleros... | Liver transplan... 45 Gy external ... Endoluminal bil... Capecitabine Pre liver trans... | 18 Years - 65 Years | Azienda Ospedaliera di Padova | |
| RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma | NCT03320980 | Hilar Cholangio... Intrahepatic Ch... | RALPPS portal vein emb... | 18 Years - 80 Years | Moscow Clinical Scientific Center | |
| Superior Bilioenteric Anastomosis by Magnetic Compressive Technique | NCT02801500 | Hilar Cholangio... Bile Duct Injur... Choledochal Cys... Biliary Calculi | Magnetic Compre... Manual Anastomo... | 18 Years - 75 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma | NCT04779788 | Hilar Cholangio... | I-125 seeds loa... Normal stent (s... | 18 Years - 80 Years | Xuzhou Central Hospital | |
| Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT01093222 | Extrahepatic Bi... Gallbladder Ade... Gallbladder Ade... Hilar Cholangio... Recurrent Extra... Recurrent Gallb... Undifferentiate... Unresectable Ex... Unresectable Ga... | Erlotinib Hydro... Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma | NCT05626127 | Hilar Cholangio... | No intervention... | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery | NCT02042443 | Adult Cholangio... Advanced Adult ... BCLC Stage C Ad... BCLC Stage D Ad... Hilar Cholangio... Localized Non-R... Recurrent Adult... Recurrent Child... Recurrent Extra... Recurrent Gallb... Stage II Gallbl... Stage III Child... Stage IIIA Gall... Stage IIIB Gall... Stage IV Childh... Stage IV Distal... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex... | Capecitabine Fluorouracil Laboratory Biom... Leucovorin Calc... Trametinib | - | National Cancer Institute (NCI) | |
| Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma | NCT03132649 | Hilar Cholangio... | 18 Years - 70 Years | Zhujiang Hospital | ||
| Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma | NCT02955771 | Hilar Cholangio... | PDT-Deuteporfin... PDT-Deuteporfin... stenting | 18 Years - | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | |
| RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma | NCT03320980 | Hilar Cholangio... Intrahepatic Ch... | RALPPS portal vein emb... | 18 Years - 80 Years | Moscow Clinical Scientific Center | |
| Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent | NCT00746538 | Unresectable Hi... | biliary stent | 18 Years - | Khon Kaen University | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery | NCT02042443 | Adult Cholangio... Advanced Adult ... BCLC Stage C Ad... BCLC Stage D Ad... Hilar Cholangio... Localized Non-R... Recurrent Adult... Recurrent Child... Recurrent Extra... Recurrent Gallb... Stage II Gallbl... Stage III Child... Stage IIIA Gall... Stage IIIB Gall... Stage IV Childh... Stage IV Distal... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex... | Capecitabine Fluorouracil Laboratory Biom... Leucovorin Calc... Trametinib | - | National Cancer Institute (NCI) | |
| Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy | NCT05551299 | Hilar Cholangio... | Photosensitizer Radiofrequency ... | 18 Years - | University of Leipzig | |
| Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT01093222 | Extrahepatic Bi... Gallbladder Ade... Gallbladder Ade... Hilar Cholangio... Recurrent Extra... Recurrent Gallb... Undifferentiate... Unresectable Ex... Unresectable Ga... | Erlotinib Hydro... Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
